175 related articles for article (PubMed ID: 3733688)
1. Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells.
Kaufman RJ; Wasley LC; Furie BC; Furie B; Shoemaker CB
J Biol Chem; 1986 Jul; 261(21):9622-8. PubMed ID: 3733688
[TBL] [Abstract][Full Text] [Related]
2. Expression of completely gamma-carboxylated recombinant human prothrombin.
Jorgensen MJ; Cantor AB; Furie BC; Furie B
J Biol Chem; 1987 May; 262(14):6729-34. PubMed ID: 3032975
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vector.
Balland A; Faure T; Carvallo D; Cordier P; Ulrich P; Fournet B; de la Salle H; Lecocq JP
Eur J Biochem; 1988 Mar; 172(3):565-72. PubMed ID: 3280312
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells.
Rehemtulla A; Roth DA; Wasley LC; Kuliopulos A; Walsh CT; Furie B; Furie BC; Kaufman RJ
Proc Natl Acad Sci U S A; 1993 May; 90(10):4611-5. PubMed ID: 8506307
[TBL] [Abstract][Full Text] [Related]
5. Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle.
Wajih N; Hutson SM; Owen J; Wallin R
J Biol Chem; 2005 Sep; 280(36):31603-7. PubMed ID: 16030016
[TBL] [Abstract][Full Text] [Related]
6. Expression of biologically active human clotting factor IX in Drosophila S2 cells: γ-carboxylation of a human vitamin K-dependent protein by the insect enzyme.
Vatandoost J; Zomorodipour A; Sadeghizadeh M; Aliyari R; Bos MH; Ataei F
Biotechnol Prog; 2012; 28(1):45-51. PubMed ID: 22012919
[TBL] [Abstract][Full Text] [Related]
7. Isolation of the human gamma-carboxylase and a gamma-carboxylase-associated protein from factor IX-expressing mammalian cells.
Lingenfelter SE; Berkner KL
Biochemistry; 1996 Jun; 35(25):8234-43. PubMed ID: 8679578
[TBL] [Abstract][Full Text] [Related]
8. Effect of propeptide mutations on post-translational processing of factor IX. Evidence that beta-hydroxylation and gamma-carboxylation are independent events.
Rabiet MJ; Jorgensen MJ; Furie B; Furie BC
J Biol Chem; 1987 Nov; 262(31):14895-8. PubMed ID: 3667614
[TBL] [Abstract][Full Text] [Related]
9. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
[TBL] [Abstract][Full Text] [Related]
10. Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site.
Bristol JA; Furie BC; Furie B
J Biol Chem; 1993 Apr; 268(10):7577-84. PubMed ID: 8463288
[TBL] [Abstract][Full Text] [Related]
11. In vitro carboxylation of a blood coagulation factor IX precursor produced by recombinant-DNA technology.
Soute BA; Balland A; Faure T; de la Salle H; Vermeer C
Thromb Haemost; 1989 Apr; 61(2):238-42. PubMed ID: 2749597
[TBL] [Abstract][Full Text] [Related]
12. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
Hertzberg MS; Ben-Tal O; Furie B; Furie BC
J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
14. Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa.
Bristol JA; Freedman SJ; Furie BC; Furie B
Biochemistry; 1994 Nov; 33(47):14136-43. PubMed ID: 7947825
[TBL] [Abstract][Full Text] [Related]
15. Human interferon omega 1: isolation of the gene, expression in Chinese hamster ovary cells and characterization of the recombinant protein.
Adolf GR; Frühbeis B; Hauptmann R; Kalsner I; Maurer-Fogy I; Ostermann E; Patzelt E; Schwendenwein R; Sommergruber W; Zöphel A
Biochim Biophys Acta; 1991 Jun; 1089(2):167-74. PubMed ID: 1647209
[TBL] [Abstract][Full Text] [Related]
16. The manufacturing process for recombinant factor IX.
Harrison S; Adamson S; Bonam D; Brodeur S; Charlebois T; Clancy B; Costigan R; Drapeau D; Hamilton M; Hanley K; Kelley B; Knight A; Leonard M; McCarthy M; Oakes P; Sterl K; Switzer M; Walsh R; Foster W
Semin Hematol; 1998 Apr; 35(2 Suppl 2):4-10. PubMed ID: 9565160
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational modifications of recombinant myotube-synthesized human factor IX.
Arruda VR; Hagstrom JN; Deitch J; Heiman-Patterson T; Camire RM; Chu K; Fields PA; Herzog RW; Couto LB; Larson PJ; High KA
Blood; 2001 Jan; 97(1):130-8. PubMed ID: 11133752
[TBL] [Abstract][Full Text] [Related]
18. Expression and purification of recombinant human angiopoietin-1 produced in Chinese hamster ovary cells.
Hwang SJ; Kim HZ; Koh GY; Lee GM
In Vitro Cell Dev Biol Anim; 2007; 43(5-6):162-7. PubMed ID: 17619940
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of recombinant factor IX.
Bond M; Jankowski M; Patel H; Karnik S; Strang A; Xu B; Rouse J; Koza S; Letwin B; Steckert J; Amphlett G; Scoble H
Semin Hematol; 1998 Apr; 35(2 Suppl 2):11-7. PubMed ID: 9565161
[TBL] [Abstract][Full Text] [Related]
20. Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.
Liebman HA; Limentani SA; Furie BC; Furie B
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3879-83. PubMed ID: 2408269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
